Showing results (81-90 of 101) with videos related to
Sort By:
Pageof 11
Cancer|October 21, 2006
Routine clinical use of alemtuzumab in patients with heavily pretreated B-cell chronic lymphocytic leukemia: a nation-wide retrospective study in AustriaMichael Fiegl, Andreas Falkner, Georg Hopfinger, et al.Gynecologic Oncology|February 17, 2007
Ovarian cancer specific kallikrein profile in effusionsIe-Ming Shih, Ritu Salani, Michael Fiegl, et al.Cancer|November 15, 2006
Prognostic relevance of cytogenetics determined by fluorescent in situ hybridization in patients having myelofibrosis with myeloid metaplasiaKathrin Strasser-Weippl, Michael Steurer, Mathias Kees, et al.Leukemia & Lymphoma|January 7, 2006
Age and hemoglobin level emerge as most important clinical prognostic parameters in patients with osteomyelofibrosis: introduction of a simplified prognostic scoreKathrin Strasser-Weippl, Michael Steurer, Mathias Kees, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2004
Combination of cytology, fluorescence in situ hybridization for aneuploidy, and reverse-transcriptase polymerase chain reaction for human mammaglobin/mammaglobin B expression improves diagnosis of malignant effusionsMichael Fiegl, Margot Haun, Anita Massoner, et al.International Archives of Allergy and Immunology|June 18, 2002
Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of diseaseWolfgang R Sperr, John-Hendrik Jordan, Michael Fiegl, et al.Wiener Klinische Wochenschrift|September 16, 2021
Real-world experience with anti-PD-1/PD-L1 monotherapy in patients with non-small cell lung cancer : A retrospective Austrian multicenter studySabine Geiger-Gritsch, Horst Olschewski, Florian Kocher, et al.Blood|October 29, 2015
Integration of innate into adaptive immune responses in ZAP-70-positive chronic lymphocytic leukemiaMichaela Wagner, Madlen Oelsner, Andrew Moore, et al.Annals of Hematology|January 31, 2025
How I diagnose and treat patients in the pre-fibrotic phase of primary myelofibrosis (pre-PMF) - practical approaches of a German expert panel discussion in 2024Martin Griesshammer, Haifa Kathrin Al-Ali, Jan-Niklas Eckardt, et al.Annals of Hematology|February 26, 2011
Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patientsMichael Fiegl, Florian Falkner, Michael Steurer, et al.Pageof 11